Azitra, Inc. Capital Expenditures
Azitra, Inc. (AZTR) reported Capital Expenditures of $54.98 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-12
- Azitra, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $40.05K, a 245.25% increase year-over-year.
- Azitra, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $14.93K.
- Azitra, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $9.25K.
- Azitra, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $3.36K, a 60.75% decline year-over-year.
- Azitra, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $24.21K, a 182.57% increase from fiscal 2024.
- Azitra, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $8.57K, a 67.72% decline from fiscal 2023.
- Azitra, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $26.54K, a 19.81% decline from fiscal 2022.
- Azitra, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $33.10K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $54.98K 10-Q · filed 2026-08-12 | $64.23K derived: sum of 3 quarters · filed 2026-08-12 | $67.59K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $14.93K 10-Q · filed 2026-05-13 | $24.18K derived: sum of 2 quarters · filed 2026-05-13 | $27.54K derived: sum of 3 quarters · filed 2026-05-13 | $39.14K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $9.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.61K derived: sum of 2 quarters · filed 2026-02-27 | $24.21K derived: sum of 3 quarters · filed 2026-08-12 | $24.21K 10-K · filed 2026-02-27 |
| 2025-09-30 | $3.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $14.96K derived: sum of 2 quarters · filed 2026-08-12 | $14.96K 10-Q · filed 2025-11-12 | $14.96K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $11.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $11.60K 10-Q · filed 2026-08-12 | $11.60K derived: sum of 3 quarters · filed 2026-08-12 | $20.17K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | $8.57K derived: sum of 3 quarters · filed 2026-05-13 | $8.57K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.57K derived: sum of 2 quarters · filed 2026-02-27 | $8.57K derived: sum of 3 quarters · filed 2026-02-27 | $8.57K 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $8.57K derived: sum of 2 quarters · filed 2025-11-12 | $8.57K 10-Q · filed 2025-11-12 | $12.23K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $3.66K derived: sum of 3 quarters · filed 2025-08-11 | $8.97K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $3.66K derived: sum of 2 quarters · filed 2025-02-24 | $8.97K derived: sum of 3 quarters · filed 2025-02-24 | $12.15K derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-12-31 | $3.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $8.97K derived: sum of 2 quarters · filed 2025-02-24 | $12.15K derived: sum of 3 quarters · filed 2025-02-24 | $26.54K 10-K · filed 2025-02-24 |
| 2023-09-30 | $5.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $8.49K derived: sum of 2 quarters · filed 2024-11-12 | $22.88K 10-Q · filed 2024-11-12 | $32.78K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $3.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $17.58K 10-Q · filed 2024-08-12 | $27.48K derived: sum of 3 quarters · filed 2024-08-12 | $19.23K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $14.39K 10-Q · filed 2024-05-09 | $24.30K derived: sum of 2 quarters · filed 2024-05-09 | $16.04K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $9.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $1.65K derived: sum of 2 quarters · filed 2024-03-15 | $33.10K 10-K · filed 2024-03-15 | |
| 2022-09-30 | -$8.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $23.20K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $31.45K 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |